SCHEMBL3018071

SCHEMBL3018071

NC(=O)c1ccc(-c2ccc(C(=O)N(O)Cc3ccccc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G10 O15496 1/20 0.53
PLA2G2A P14555 1/20 0.53
RORC P51449 2/20 0.51
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
PARP10 Q53GL7 1/20 0.46
AOC3 Q16853 2/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
PARP1 P09874 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7646415 0.83 HSD11B1 (0.54) TSHRTDP1L3MBTL1MEN1KMT2A
SCHEMBL14875870 0.83 MKNK1 (0.50) PLA2G10PLA2G2ARORCMKNK1MKNK2
SCHEMBL28681773 0.82 KMT2A (0.65) PLA2G10PLA2G2APARP10MAPTPOLB
SCHEMBL3033680 0.80 POLB (0.48) PLA2G10PLA2G2ARORCMKNK1MKNK2
SCHEMBL6489911 0.79 PLA2G10 (0.54) PLA2G10PLA2G2ARORCMKNK1MKNK2
SCHEMBL9504638 0.78 ALOX5 (0.64) MEN1KMT2AHDAC3HDAC1HDAC7
SCHEMBL27547501 0.76 MAOB (0.56) MEN1KMT2AALDH1A1HDAC6
SCHEMBL3036832 0.76 HPGD (0.57) PLA2G10PLA2G2AMKNK1MKNK2PARP10
SCHEMBL27626919 0.75 MKNK1 (0.71) PLA2G10PLA2G2AMKNK1MKNK2PARP10
SCHEMBL153199 0.75 MKNK1 (0.71) PLA2G10PLA2G2AMKNK1MKNK2PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 PLA2G10 4001/4885PLA2G2A 3304/4885RORC 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.